BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26370014)

  • 1. Statins for Primary Prevention in Adults Aged 75 Years or Older.
    Reidenberg MM
    Ann Intern Med; 2015 Sep; 163(6):481. PubMed ID: 26370014
    [No Abstract]   [Full Text] [Related]  

  • 2. Statins for Primary Prevention in Adults Aged 75 Years or Older.
    Odden MC; Goldman L; Bibbins-Domingo K
    Ann Intern Med; 2015 Sep; 163(6):482. PubMed ID: 26370015
    [No Abstract]   [Full Text] [Related]  

  • 3. Statins for Primary Prevention in Adults Aged 75 Years or Older.
    Robinson JG
    Ann Intern Med; 2015 Sep; 163(6):481. PubMed ID: 26370013
    [No Abstract]   [Full Text] [Related]  

  • 4. Statins for primary prevention in older adults.
    Ann Intern Med; 2015 Apr; 162(8):I-28. PubMed ID: 25894041
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-effectiveness of statins in older adults: further evidence that less is more.
    Rich MW
    Ann Intern Med; 2015 Apr; 162(8):590-1. PubMed ID: 25894030
    [No Abstract]   [Full Text] [Related]  

  • 6. Prescribing statins in general practice: who decides?
    Steel N; Fleetcroft B; Hassan Y
    Br J Gen Pract; 2017 Jun; 67(659):246-247. PubMed ID: 28546390
    [No Abstract]   [Full Text] [Related]  

  • 7. [Statins in primary prevention - a must for the general practitioner?].
    Zoller M
    Praxis (Bern 1994); 2011 Jul; 100(14):859-60. PubMed ID: 21732299
    [No Abstract]   [Full Text] [Related]  

  • 8. The efficacy and cost-effectiveness of statins in low-risk patients.
    Gupta AK
    CMAJ; 2011 Nov; 183(16):1821-3. PubMed ID: 22025650
    [No Abstract]   [Full Text] [Related]  

  • 9. "Polypill" to fight cardiovascular disease: cost effectiveness of statins for primary prevention of cardiovascular events is questionable.
    Messori A; Santarlasci B; Trippoli S; Vaiani M
    BMJ; 2003 Oct; 327(7418):808-9; discussion 809; author reply 809-10. PubMed ID: 14525889
    [No Abstract]   [Full Text] [Related]  

  • 10. Cost-effectiveness of atorvastatin in the prevention of cardiovascular events in diabetic patients: a French adaptation of CARDS.
    Lafuma A; Colin X; Solesse A
    Arch Cardiovasc Dis; 2008 May; 101(5):327-32. PubMed ID: 18656091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Atorvastatin in primary prevention].
    Kültürsay H
    Turk Kardiyol Dern Ars; 2009 Mar; 37 Suppl 2():17-22. PubMed ID: 19404046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins for millions more?
    Lancet; 2014 Feb; 383(9918):669. PubMed ID: 24560042
    [No Abstract]   [Full Text] [Related]  

  • 13. Statins for Primary Prevention of Cardiovascular Disease: Review of Evidence and Recommendations for Clinical Practice.
    Kazi DS; Penko JM; Bibbins-Domingo K
    Med Clin North Am; 2017 Jul; 101(4):689-699. PubMed ID: 28577620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [How far the rates of cholesterol have to be lowered in primary prevention?].
    Rodondi N
    Rev Med Suisse; 2010 Mar; 6(239):483-4. PubMed ID: 20373693
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost-effectiveness of statins in the primary prevention of cardiovascular disease: a systematic review and economic analysis for Belgium.
    Neyt M; De Laet C; Van Brabandt H; Franco O; Ramaekers D
    Acta Cardiol; 2009 Feb; 64(1):1-10. PubMed ID: 19317290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of statins for primary prevention in patients newly diagnosed with type 2 diabetes in the Netherlands.
    de Vries FM; Denig P; Visser ST; Hak E; Postma MJ
    Value Health; 2014 Mar; 17(2):223-30. PubMed ID: 24636380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of enhancing adherence to therapy with statins in the setting of primary cardiovascular prevention. Evidence from an empirical approach based on administrative databases.
    Corrao G; Scotti L; Zambon A; Baio G; Nicotra F; Conti V; Capri S; Tragni E; Merlino L; Catapano AL; Mancia G
    Atherosclerosis; 2011 Aug; 217(2):479-85. PubMed ID: 21592477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins for primary prevention in older adults: who is high risk, who is old, and what denotes primary prevention?
    Zieman SJ; Ouyang P
    Ann Intern Med; 2010 Apr; 152(8):528-30, W183. PubMed ID: 20404384
    [No Abstract]   [Full Text] [Related]  

  • 19. Statins for Primary Prevention of Cardiovascular Disease.
    Lippi G; Plebani M
    Trends Pharmacol Sci; 2017 Feb; 38(2):111-112. PubMed ID: 28017363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Primary prevention of cardiovascular disease with statin in type 2 diabetes mellitus: Is it time to change our strategy?].
    Albert Fàbregas L; González-Clemente JM
    Med Clin (Barc); 2014 Apr; 142(8):358-9. PubMed ID: 24602748
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.